Advancing Effective Clinical Trial Designs for Myelofibrosis.
Sign Up to like & getrecommendations! Published in 2021 at "Hematology/oncology clinics of North America"
DOI: 10.1016/j.hoc.2020.12.009
Abstract: Design features of phase I, II, and III clinical trials of pharmaceutical interventions in myelofibrosis (MF) are discussed. Model-assisted and model-based designs for phase I trials are useful for maximizing therapeutic benefit and include novel… read more here.
Keywords: clinical trial; designs myelofibrosis; trial designs; effective clinical ... See more keywords